Hematopoietic Stem Cell Transplantation Activity for Lymphoma: A Multicentric Study By the Transplantation and Cellular Therapy Mexican Working Group

Colunga‐Pedraza, Perla R.; León, Andrés Gómez‐De; Rios, Christianne Bourlon De Los; Vargas-Serafin, Cesar; Luevano, Myrna Patricia Pequeño; Amador, Lauro Fabian; García-Castillo, Carolina; Alvarado, Martha; Ruíz‐Argüelles, Guillermo J.; Olaya-Vargas, Alberto; Peña-Lozano, Samantha P.; Villarreal, Guadalupe González; López, Elías Eugenio González; Yah, Gabriela Cardoso; Murrieta-Álvarez, Iván; Martinez, Luis Mario Villela; Almaguer, David Gómez

doi:10.1182/blood-2022-169096

Cited by 2 publications

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…US-based patients who traveled to Mexico were more likely to be seeking chemotherapy, surgery, and radiation, which may be due to the lower cost of these treatments in Mexico. In contrast, Mexico-based patients traveled to the US to obtain therapies which are either unavailable or not covered in Mexico such as immunotherapy, stem cell transplantation, and cellular therapy [ 23 , 24 ]. Interestingly, US-based patients traveled to Mexico often to undergo imaging and other diagnostic tests, which may be due to their affordability and accessibility, particularly for patients with limited health insurance.…”

Section: Discussionmentioning

confidence: 99%

Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists

LaPelusa,

Verduzco-Aguirre,

Diaz

et al. 2023

Global Health

View full text Add to dashboard Cite

Background The US-Mexico border is the busiest in the world, with millions of people crossing it daily. However, little is known about cross-border utilization of cancer care, or about the reasons driving it. We designed a cross sectional online survey to understand the type of care patients with cancer who live in the US and Mexico seek outside their home country, the reasons why patients traveled across the border to receive care, and the barriers faced when seeking cross-border care. Results The online survey was sent to the 248 cancer care providers working in the six Mexican border states who were registered members of the Mexican Society of Oncology. Responses were collected between September-November 2022. Sixty-six providers (response rate 26%) completed the survey. Fifty-nine (89%) reported interacting with US-based patients traveling to Mexico to receive various treatment modalities, with curative surgery (n = 38) and adjuvant chemotherapy (n = 31) being the most common. Forty-nine (74%) reported interacting with Mexico-based patients traveling to the US to receive various treatment modalities, with immunotherapy (n = 29) and curative surgery (n = 27) being the most common. The most frequently reported reason US-based patients sought care in Mexico was inadequate health insurance (n = 45). The most frequently reported reason Mexico-based patients sought care in the US was patients’ perception of superior healthcare (n = 38). Conclusions Most Mexican oncologists working along the Mexico-US border have interacted with patients seeking or receiving binational cancer care. The type of care sought, as well as the reasons for seeking it, differ between US and Mexico-based patients. These patterns of cross-border healthcare utilization highlight unmet needs for patients with cancer in both countries and call for policy changes to improve outcomes in border regions.

show abstract

Section: Discussionmentioning

confidence: 99%